Cerdelga 84 mg/1
eliglustat · CAPSULE · Genzyme Corporation
No Recall History
Plain English
Cerdelga is a capsule containing eliglustat at 84 mg/1, taken oral. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- Cerdelga
- Generic Name
- eliglustat
- NDC Code (Product)
58468-0220- Manufacturer
- Genzyme Corporation
- Strength
- 84 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA205494
- Drug Class
- Glucosylceramide Synthase Inhibitor [EPC]
- Marketing Start
- 09/03/2014
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
weight increased153 reports
weight decreased132 reports
product dose omission in error131 reports
fatigue76 reports
product dose omission issue75 reports
arthralgia50 reports
nausea48 reports
dyspepsia46 reports
fall44 reports
covid-1942 reports
Frequently Asked Questions
What is Cerdelga used for?
Cerdelga contains eliglustat. It is a capsule taken oral. Consult your doctor for specific uses.
Is Cerdelga a controlled substance?
Cerdelga is not classified as a controlled substance by the DEA.
What is the generic name for Cerdelga?
The generic name for Cerdelga is eliglustat. There are no other listed brand versions of eliglustat.
What is the NDC code for Cerdelga 84 mg/1?
The NDC (National Drug Code) for Cerdelga 84 mg/1 is 58468-0220, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)